These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17992016)

  • 21. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of arginine-nitric oxide pathway in patients with Alzheimer disease.
    Vural H; Sirin B; Yilmaz N; Eren I; Delibas N
    Biol Trace Elem Res; 2009; 129(1-3):58-64. PubMed ID: 19099206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
    Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism.
    Chou FF; Chen JB; Hsieh KC; Liou CW
    Surgery; 2008 Apr; 143(4):526-32. PubMed ID: 18374050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium supplementation in the treatment of dementia patients.
    Ozturk S; Cillier AE
    Med Hypotheses; 2006; 67(5):1223-5. PubMed ID: 16790324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects.
    Bo M; Massaia M; Zannella P; Cappa G; Ferrario E; Rainero I; Arvat E; Giordano R; Molaschi M
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1065-70. PubMed ID: 16977674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in older Belgian people: comparison between people with dementia, mild cognitive impairment, and controls.
    Missotten P; Squelard G; Ylieff M; Di Notte D; Paquay L; De Lepeleire J; Fontaine O
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1103-9. PubMed ID: 18213606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive decline and survival in Alzheimer's disease according to education level.
    Bruandet A; Richard F; Bombois S; Maurage CA; Masse I; Amouyel P; Pasquier F
    Dement Geriatr Cogn Disord; 2008; 25(1):74-80. PubMed ID: 18042993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of life in Alzheimer's disease].
    Baquero M; Peset V; Burguera JA; Salazar-Cifre A; Boscá-Blasco ME; del Olmo-Rodríguez A; Valero-Merino C; Muñoz-Lacalle RA;
    Rev Neurol; 2009 Oct 1-15; 49(7):337-42. PubMed ID: 19774526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac sympathovagal modulation evaluated by short-term heart interval variability is subtly impaired in Alzheimer's disease.
    de Vilhena Toledo MA; Junqueira LF
    Geriatr Gerontol Int; 2008 Jun; 8(2):109-18. PubMed ID: 18713163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the 7-Minute Screen for the detection of early-stage Alzheimer's disease.
    Ijuin M; Homma A; Mimura M; Kitamura S; Kawai Y; Imai Y; Gondo Y
    Dement Geriatr Cogn Disord; 2008; 25(3):248-55. PubMed ID: 18270487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional status is associated with disease progression in very mild Alzheimer disease.
    Ousset PJ; Nourhashemi F; Reynish E; Vellas B
    Alzheimer Dis Assoc Disord; 2008; 22(1):66-71. PubMed ID: 18317249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
    Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered ionized magnesium levels in mild-to-moderate Alzheimer's disease.
    Barbagallo M; Belvedere M; Di Bella G; Dominguez LJ
    Magnes Res; 2011 Sep; 24(3):S115-21. PubMed ID: 21951617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatotype in Alzheimer's disease.
    Buffa R; Lodde M; Floris G; Zaru C; Putzu PF; Marini E
    Gerontology; 2007; 53(4):200-4. PubMed ID: 17347566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ionized magnesium and calcium levels in adult patients with seizures.
    Sinert R; Zehtabchi S; Desai S; Peacock P; Altura BT; Altura BM
    Scand J Clin Lab Invest; 2007; 67(3):317-26. PubMed ID: 17454846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of depression on serum VEGF level in Alzheimer's disease.
    Jung J; Kim S; Yoon K; Moon Y; Roh D; Lee S; Choi K; Jung J; Kim D
    Dis Markers; 2015; 2015():742612. PubMed ID: 25838619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.